Articles by Jill Wechsler - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jill Wechsler

Breakthrough Therapies Raise Manufacturing Issues

Nov 8, 2013

Breakthrough Therapies Raise Manufacturing Issues

FDA Promotes Personalized Medicine

Nov 8, 2013

FDA Promotes Personalized Medicine

FDA Moves to Curb Drug Shortages

Nov 8, 2013

FDA Moves to Curb Drug Shortages

Generic Drug Super Office Takes Shape

Nov 8, 2013

Generic Drug Super Office Takes Shape

Congress Revises Rules for Drug Compounding and Supply-Chain Security

Legislators agree on a limited bill affirming FDA authority over compounders while setting up a process for national drug tracking.
Nov 2, 2013

Legislators agree on a limited bill affirming FDA authority over compounders while setting up a process for national drug tracking.

FDA Updates Foreign Operations

Oct 4, 2013

Budget issues and changing global markets are prompting FDA to revise its growing network of overseas offices.

FDA Seeks Metrics to Define Drug Quality

Manufacturing standards are considered key to preventing drug recalls and shortages.
Oct 2, 2013

Manufacturing standards are considered key to preventing drug recalls and shortages.

FDA Works to Secure Drug Supply Chain

New policies aim to strengthen inspection and oversight processes.
Sep 2, 2013

New FDA supply chain policies aim to strengthen inspection and oversight processes.

Generic Drugs Face Regulatory and Scientific Challenges

FDA funds research to further development of innovative generics.
Aug 2, 2013

FDA funds research to further development of innovative generics, while working to address review and approval issues.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
24%
Attracting a skilled workforce
30%
Obtaining/maintaining adequate financing
15%
Regulatory compliance
30%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
FindPharma Custom Search
Click here